Two main techniques are currently used to determine dMMR/MSI status: immunohistochemistry (IHC), which detects loss of MMR protein expression in the tumour (dMMR status), and molecular testing, which determines the fragment size of microsatellite loci on tumor DNA (MSI status). The gene discussed is MRC1; the disease is neoplasm.